In Vivo Evaluation of Site-Specifically PEGylated Chemically Self-Assembled Protein Nanostructures.
In Vivo Evaluation of Site-Specifically PEGylated Chemically Self-Assembled Protein Nanostructures.
复制标题
体内特定于定位的化学自我组装蛋白纳米结构的体内评估。
DOI:
10.1021/acs.molpharmaceut.6b00110
复制
发表时间:
2016-07-05
影响因子:
4.9
通讯作者:
Kumarapperuma SC
中科院分区:
文献类型:
--
作者:
Shah R;Petersburg J;Gangar AC;Fegan A;Wagner CR;Kumarapperuma SC
Chemically Self-Assembled Nanorings (CSANs) are made of dihydrofolate reductase (DHFR) fusion proteins and have been successfully used in vitro for cellular cargo delivery and cell surface engineering applications. However, CSANs have yet to be evaluated for their in vivo stability, circulation and tissue distribution. In an effort to evaluate CSANs in vivo, we engineered a site-specifically PEGylated epidermal growth factor receptor (EGFR) targeting DHFR molecules, characterized their self-assembly in to CSANs with bivalent methotrexates (bis-MTX), visualized their in vivo tissue localization by microPET/CT imaging and determined their ex vivo organ biodistribution by tissue-based gamma counting. A dimeric DHFR (DHFR2) molecule fused with a C-terminal EGFR targeting peptide (LARLLT) was engineered to incorporate a site-specific ketone functionality using unnatural amino-acid mutagenesis. Aminooxy-PEG, of differing chain lengths, was successfully conjugated to the protein using oxime chemistry. These proteins were self-assembled into CSANs with bis-MTX DHFR dimerizers and characterized by size exclusion chromatography and dynamic light scattering. In vitro binding studies were performed with fluorescent CSANs assembled using bis-MTX-FITC, while in vivo microPET/CT imaging was performed with radiolabeled CSANs assembled using bis-MTX-DOTA[64Cu]. PEGylation reduced the uptake of anti-EGFR CSANs by mouse macrophages (RAW 264.7) up to 40% without altering the CSAN’s binding affinity towards U-87 MG glioblastoma cells in vitro. A significant time dependent tumor accumulation of 64Cu labeled anti-EGFR-CSANs was observed by microPET/CT imaging and biodistribution studies in mice bearing U-87 MG xenografts. PEGylated CSANs demonstrated a reduced uptake by the liver, kidneys and spleen resulting in high contrast tumor imaging within an hour of intravenous injection (9.6% ID/g), and continued to increase up to 24 h (11.7% ID/g) while the background signal diminished. CSANs displayed an in vivo profile between that of rapidly clearing small molecules and slow clearing antibodies. Thus CSANs offer a modular, programmable and stable protein based platform that can be used for in vivo drug delivery and imaging applications.
登录
查看更多内容
影响因子:
15
作者:
Li Q;So CR;Fegan A;Cody V;Sarikaya M;Vallera DA;Wagner CR
通讯作者:
Wagner CR
DOI:
10.2217/17435889.3.5.703
发表时间:
2008-10
期刊:
Nanomedicine (London, England)
影响因子:
--
作者:
Longmire M;Choyke PL;Kobayashi H
通讯作者:
Kobayashi H
影响因子:
4.7
作者:
Basu, Amartya;Yang, Karen;Filpula, David
通讯作者:
Filpula, David
影响因子:
4.7
作者:
Lim, Reyna K. V.;Yu, Shan;Kazane, Stephanie A.
通讯作者:
Kazane, Stephanie A.
影响因子:
16.6
作者:
Gabrielse, Kari;Gangar, Amit;Wagner, Carston R.
通讯作者:
Wagner, Carston R.